Kineta Receives $1,627,498 New Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=13beeeb2-5cfe-49d3-9657-c55049c55c9f - Date
5/19/2014 - Company Name
Kineta - Mailing Address
219 Terry Ave N Seattle, WA 98109 USA - Company Description
Through Kineta, our pioneering team is dedicated to further study of innate immunity with an aggressive strategy to develop early stage programs for powerful new antiviral and immune modulating drugs. - Website
http://www.kinetabio.com - Transaction Type
Venture Equity - Transaction Amount
$1,627,498 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities. - M&A Terms
- Venture Investor
